| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DNAJC10 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | MAPK9 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | PAGE2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | C16orf58 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | SDR42E2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | FXYD4 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | NEB | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ME2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | TUT1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
